Caesars Entertainment Inc
Change company Symbol lookup
Select an option...
CZR Caesars Entertainment Inc
NFLX Netflix Inc
REGN Regeneron Pharmaceuticals Inc
NSC Norfolk Southern Corp
WM Waste Management Inc
ITOS Iteos Therapeutics Inc
CCLD CareCloud Inc
JEF Jefferies Financial Group Inc
RSASF Resaas Services Inc
VRNT Verint Systems Inc
Go

Consumer Discretionary : Hotels, Restaurants & Leisure | Mid Cap Blend
Company profile

Caesars Entertainment, Inc. is a gaming and hospitality company that owns and operates gaming facilities. Its principal operating activities are reported through geographic regions and reportable segments, including West, Midwest, South, East and Central. The West segment includes Silver Legacy Resort Casino, and Tropicana Laughlin Hotel and Casino. The Midwest segment includes Isle Casino Waterloo and Isle Casino Bettendorf. The South segment includes Isle Casino Racing Pompano Park, Isle of Capri Casino Lula, Isle of Capri Casino Hotel Lake Charles, Trop Casino Greenville, and Belle of Baton Rouge Casino and Hotel. The East segment includes Presque Isle Downs and Casino, ldorado Gaming Scioto Downs, and Tropicana Casino and Resort. The Central segment includes Tropicana Evansville, Lumiere Place Casino and Grand Victoria Casino.

Closing Price
$55.22
Day's Change
1.72 (3.21%)
Bid
--
Ask
--
B/A Size
--
Day's High
55.22
Day's Low
52.85
Volume
(Light)
Volume:
1,322,947

10-day average volume:
3,301,074
1,322,947

Novavax Inc. Stock Rises Tuesday, Still Underperforms Market

5:13 pm ET November 15, 2022 (MarketWatch)
Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Novavax Inc. (NVAX) inched 0.61% higher to $23.22 Tuesday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index rising 1.45% to 11,358.41 and the Dow Jones Industrial Average rising 0.17% to 33,592.92. Novavax Inc. closed $213.28 below its 52-week high ($236.50), which the company achieved on December 20th.

The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Replimune Group Inc. (REPL) fell 4.60% to $19.69, VBI Vaccines Inc. (VBIV) rose 10.34% to $0.68, and AnaptysBio Inc. (ANAB) fell 0.86% to $29.96. Trading volume (4.5 M) remained 673,661 below its 50-day average volume of 5.2 M.

Data source: Dow Jones Market Data, FactSet. Data compiled November 15, 2022.

	

(END) Dow Jones Newswires

November 15, 2022 17:13 ET (22:13 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.